Literature DB >> 18309706

The impact of leprosy control on the transmission of M. leprae: is elimination being attained?

Jan Hendrik Richardus1, J Dik F Habbema.   

Abstract

In 1991 the World Health Assembly decided to 'eliminate leprosy as a public health problem' by the year 2000. Elimination was defined as reducing the global prevalence of the disease to less than 1 case per 10,000. In 2000 the World Health Organization (WHO) announced that elimination was reached globally. Conventionally control of disease is defined as the reduction of disease burden to a locally acceptable level. Elimination of disease is defined as the reduction to zero of the incidence in a defined geographical area, and eradication is defined as the permanent reduction to zero of the worldwide incidence of infection caused by a specific agent. In leprosy however, WHO limited elimination to control instead of transmission, by using prevalence instead of incidence of disease. Leprosy statistics usually report on prevalence and new case detection. Prevalence is linked to length of treatment, which has changed over time. Trends in new case detection rates only reflect trends in incidence rates when no changes occur in case detection, but in the past 25 years case detection in leprosy has been determined strongly by operational factors. For the leprosy elimination strategy it was assumed that MDT would reduce transmission of M. leprae, but there is no convincing evidence for this. Data for evaluating the impact of MDT on transmission are not readily available because leprosy has a long incubation period. Also declines in case detection may have other causes, such as BCG vaccination. Mathematical modelling of the transmission and control of leprosy showed that the elimination strategy reduces transmission slowly, with a predicted annual decline in incidence ranging from 2% to 12%. Early case finding was the key factor to attain this decline. Future projections of the global leprosy burden indicated that 5 million new cases would arise between 2000 and 2020, and that in 2020 there would be 1 million people with WHO grade 2 disability. It is concluded that substantial progress has been made to control leprosy, but when elimination of disease is defined as the reduction to zero of the incidence, leprosy is definitely not eliminated. To attain elimination of leprosy it is necessary to find effective interventions to interrupt transmission of M. leprae and practical diagnostic tools to detect levels of infection that can lead to transmission. This requires extensive research in the areas of epidemiology and microbiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18309706

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  27 in total

1.  Leprosy Elimination: Progress and Challenges in Nigeria; Kaduna State TB and Leprosy Control Programme as a Case Study.

Authors:  Gidado Mustapha; Obasanya Joshua Olusegu; Sani Mustapha; Adesigbin Clement; Tahir Dahiru; J Gagere; Adejumo Adeleji Olusola
Journal:  Afr J Infect Dis       Date:  2012

2.  Potential effect of the World Health Organization's 2011-2015 global leprosy strategy on the prevalence of grade 2 disability: a trend analysis.

Authors:  Catharina J Alberts; W Cairns S Smith; Abraham Meima; Lamei Wang; Jan Hendrik Richardus
Journal:  Bull World Health Organ       Date:  2011-04-29       Impact factor: 9.408

3.  Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease.

Authors:  José Wilton Queiroz; Gutemberg H Dias; Maurício Lisboa Nobre; Márcia C De Sousa Dias; Sérgio F Araújo; James D Barbosa; Pedro Bezerra da Trindade-Neto; Jenefer M Blackwell; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

4.  Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical research.

Authors:  Koichi Suzuki; Toshifumi Udono; Michiko Fujisawa; Kazunari Tanigawa; Gen'ichi Idani; Norihisa Ishii
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

5.  Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.

Authors:  Willemijn J Idema; Istvan M Majer; David Pahan; Linda Oskam; Suzanne Polinder; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

6.  Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts--a pilot study from India.

Authors:  Surajita Banerjee; Kamalesh Sarkar; Soma Gupta; Prasanta Sinha Mahapatra; Siddhartha Gupta; Samudra Guha; Debasis Bandhopadhayay; Chaitry Ghosal; Suman Kalyan Paine; Rathindra Nath Dutta; Nibir Biswas; Basudev Bhattacharya
Journal:  BMC Infect Dis       Date:  2010-08-24       Impact factor: 3.090

7.  Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.

Authors:  Malcolm S Duthie; Maria T Pena; Amit P Khandhar; Alessandro Picone; Zachary MacMIllen; Richard W Truman; Linda B Adams; Steven G Reed
Journal:  Appl Microbiol Biotechnol       Date:  2020-03-10       Impact factor: 4.813

8.  Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination.

Authors:  Wim H van Brakel; Benyamin Sihombing; Hernani Djarir; Kerstin Beise; Laksmi Kusumawardhani; Rita Yulihane; Indra Kurniasari; Muhammad Kasim; Kadek I Kesumaningsih; Annelies Wilder-Smith
Journal:  Glob Health Action       Date:  2012-07-20       Impact factor: 2.640

9.  Active surveillance of Hansen's Disease (leprosy): importance for case finding among extra-domiciliary contacts.

Authors:  Maria L N Moura; Kathryn M Dupnik; Gabriel A A Sampaio; Priscilla F C Nóbrega; Ana K Jeronimo; Jose M do Nascimento-Filho; Roberta L Miranda Dantas; Jose W Queiroz; James D Barbosa; Gutemberg Dias; Selma M B Jeronimo; Marcia C F Souza; Maurício L Nobre
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

10.  Leprosy--evolution of the path to eradication.

Authors:  Sunil Dogra; Tarun Narang; Bhushan Kumar
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.